ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,687 | -24.6% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $3,566 | +40.4% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,540 | -37.4% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $4,056 | +35.2% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $3,000 | -25.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $4,000 | -20.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $5,000 | -28.6% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $7,000 | +16.7% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $6,000 | -25.0% | 100 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $8,000 | +14.3% | 100 | 0.0% | 0.00% | +100.0% |
| Q1 2021 | $7,000 | -12.5% | 100 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $8,000 | +100.0% | 100 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $4,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $4,000 | +33.3% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $3,000 | -50.0% | 100 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $6,000 | +100.0% | 100 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |